2Brownlee M.Biochemistry and molecular cell biology of diabetic complications[J].Nature,2001,414(6865):813-820.
3Wei XF,Zhou QG,Hou FF,et al.Advanced oxidation protein products induce mesangial cell perturbation through PKC-dependent activation of NADPH oxidase[J].Am J Physiol Renal Physiol,2009,296(2):F427-437.
4Shi XY,Hou FF,Niu HX,et al.Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase[J].Endocrinology,2008,149(4):1829-1839.
5Li HY,Hou FF,Zhang X,et al.Advanced oxidation protein products accelerate renal fibrosis in a remnant kidney model[J].J Am Soc Nephrol,2007,18(2):528-538.
6Hou FF,Xie D,Zhang X,et al.Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study:a randomized controlled study of benazepril and losartan in chronic renal insufficiency[J].J Am Soc Nephrol,2007,18(6):1889-1898.
7Ha H,Yu MR,Choi YJ,et al.Role of high glucose-induced nuclear factor-kappa B activation in monocyte chemoattractant protein-1 expression by mesangial cells[J].J Am Soc Nephrol,2002,13(14):894-902.
